Updates and news related to prostate cancer:

 

Triple Therapy Boosts Survival

Adding androgen receptor signaling inhibitors (ARSI) to a treatment regimen consisting of docetaxel and androgen deprivation therapy (ADT) can lead to better survival outcomes in patients with metastatic hormone-sensitive prostate cancer (mHSPC).

The Effects of Exercise Before and After Diagnosis

This article serves as a summary of the literature published in the past 3 years, documenting the impact of exercise and physical activity on prostate cancer development and on cancer-specific, treatment-related, and patient-reported outcomes.

Civica Announces Launch of First Product

Abiraterone acetate, used together with steroid medication (prednisone) to treat prostate cancer that has spread to other parts of the body, now available at significant savings.

Contribute a Story

Do you have something to contribute? Send it to pchelp@pcsanm.org